Skip to main content
Log in

ASO Author Reflections: Surgical Resection Should be Considered in the Multidisciplinary Care of Patients with Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bosman FT. World Health Organization, International Agency For Research On Cancer. Who classification of tumours of the digestive system. 4th edn. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  2. Lloyd RV, Osamura RY, KlöPpel G, Rosai J. Classification of tumours of endocrine organs. 4th edn. Lyon: Iarc Press; 2017.

    Google Scholar 

  3. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 who classification of tumours of the digestive system. Histopathology. 2020;76(2):182–8. https://doi.org/10.1111/His.13975.

    Article  Google Scholar 

  4. Rindi G, Klersy C, Albarello L, et al. Competitive testing of the WHO 2010 versus the who 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study. Neuroendocrinology. 2018;107(4):375–86. https://doi.org/10.1159/000494355.

    Article  CAS  Google Scholar 

  5. Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103(2):186–94. https://doi.org/10.1159/000443172.

    Article  CAS  Google Scholar 

  6. Howe JR, Merchant NB, Conrad C, et al. The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(1):1–33. https://doi.org/10.1097/Mpa.0000000000001454.

    Article  Google Scholar 

  7. Borbon LC, Tran CG, Sherman SK, et al. Is there a role for surgical resection of grade 3 neuroendocrine neoplasms? Ann Surg Oncol. 2022. https://doi.org/10.1245/S10434-022-12100-3.

    Article  Google Scholar 

  8. Ziogas IA, Tasoudis PT, Borbon LC, et al. Surgical management of G3 gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12643-5

    Article  Google Scholar 

Download references

Acknowledgment

This work was supported by Iowa SPORE Grant P50 CA174521-01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James R. Howe MD, FACS.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ziogas, I.A., Dillon, J.S., Chandrasekharan, C. et al. ASO Author Reflections: Surgical Resection Should be Considered in the Multidisciplinary Care of Patients with Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms. Ann Surg Oncol 30, 161–162 (2023). https://doi.org/10.1245/s10434-022-12644-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12644-4

Navigation